PW Medtech Group Limited (FRA:PWE)

Market Cap	213.68M +27.8%
Revenue (ttm)	100.42M +21.7%
Net Income	17.42M -3.8%
EPS	0.01 +0.0%
Shares Out	n/a
PE Ratio	12.27
Forward PE	n/a
Dividend	0.01 (8.12%)
Ex-Dividend Date	Nov 3, 2025

Volume	n/a
Average Volume	131
Open	0.1310
Previous Close	0.1320
Day's Range	0.1310 - 0.1310
52-Week Range	0.0920 - 0.1830
Beta	n/a
RSI	53.40
Earnings Date	Mar 27, 2026

About PW Medtech Group

PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, and internationally. It operates through three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical device...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1997
• Employees: 1,356
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PWE

Financial Performance

In 2024, PW Medtech Group's revenue was 768.90 million, an increase of 13.90% compared to the previous year's 675.08 million. Earnings were 150.78 million, a decrease of -1.57%.

Financial numbers in CNY